Food and Drug Department (FDD), Lao PDR Read more about Food and Drug Department (FDD), Lao PDR This presentation gives an overview of enhancing the quality and safety of medicine in Southeast Asia, focusing on the organization, legislation, pharmacovigilance system, challenges, and next steps in Lao PDR.
Thai Food and Drug Administration Read more about Thai Food and Drug Administration This presentation gives an overview of the efforts to improve the maturity capacity of pharmacovigilance in Thailand, including strategies, best practices, and specific tasks to enhance health product safety surveillance and reporting systems.
Enhancing the Quality and Safety of Medicine in Southeast Asia Read more about Enhancing the Quality and Safety of Medicine in Southeast Asia This presentation gives an overview on the ADB SECURE Project's efforts to enhance the quality and safety of medicine in Southeast Asia through improving the maturity level of National Regulatory Authorities.
Therapeutic Goods Administration's Perspective on Pharmacovigilance in the Indo-Pacific Region Read more about Therapeutic Goods Administration's Perspective on Pharmacovigilance in the Indo-Pacific Region This presentation gives an overview on the Regulatory Strengthening Program (RSP) by TGA in the Indo-Pacific region to improve pharmacovigilance systems and address challenges in regulatory frameworks, fragmented systems, underreporting of adverse events, and collaboration issues.
Global Policy and Perspectives on Pharmacovigilance and National Regulatory Authorities Read more about Global Policy and Perspectives on Pharmacovigilance and National Regulatory Authorities This presentation gives an overview on pharmacovigilance in Southeast Asia, highlighting key challenges, the WHO Programme for International Drug Monitoring, low reporting from LMICs, and a global smart pharmacovigilance strategy.
Soulyvanh Keokinnaly Keywords Quality and Safety of Medicine in Southeast Asia Health wellbeing ADB SECURE Read more about Soulyvanh Keokinnaly Soulyvanh Keokinnaly is the Chief of the Hospital Pharmacy Management Division, responsible for ensuring the availability of high-quality, safe, and effective essential medicines in health facilities at all levels. His role includes promoting the rational use of medicines and monitoring drug safety surveillance. He holds a Master’s degree in Public Health from the University of Health Sciences, Lao PDR (2015), a Bachelor’s degree in Pharmacy (2003), and a Diploma in Assistance Pharmacy (1993).
Pattreya Pokhagul Keywords Quality and Safety of Medicine in Southeast Asia Health wellbeing ADB SECURE Read more about Pattreya Pokhagul Ms. Pattreya Pokhagul is a senior professional pharmacist at the Health Product Vigilance Center, Strategy and Planning Division, and the Food and Drug Administration (FDA) of Thailand. She holds a Bachelor of Pharmacy, Bachelor of Economics, and a Master of Pharmacy in Hospital and Clinical Pharmacy. She is a Board Member of the College of Pharmaceutical and Health Consumer Protection of Thailand and a Fellow of the Federation of Asian Pharmaceutical Associations College of Pharmacy.
Kyi Thar Keywords Quality and Safety of Medicine in Southeast Asia Health wellbeing ADB SECURE Read more about Kyi Thar Dr. Kyi Thar is a medical doctor, public health and pharmacovigilance expert. He has extensive working experience as a consultant for ADB over eight years in various health projects. Previously, he was a Technical Officer for surveillance and epidemiology at the WHO SEARO and the WHO DPR Korea. He was assigned as a Public Health Expert for UNOPS and Technical Director for the Malaria Consortium and Community Partners International. He also served as the Assistant Director for the Ministry of Health in Myanmar.
Abraham Daniel Keywords Quality and Safety of Medicine in Southeast Asia Health wellbeing ADB SECURE Read more about Abraham Daniel Dr. Abraham Daniel is a registered pharmacist with over 15 years of experience spanning community and hospital pharmacy, academic research, pharmaceutical industry roles, and regulatory affairs. He completed his PhD at the University of Tasmania in 2020, focusing on novel therapeutics for progressive vision loss.
Adrien Inoubli Keywords Quality and Safety of Medicine in Southeast Asia Health wellbeing ADB SECURE Read more about Adrien Inoubli Dr. Adrien Inoubli has been Regional Adviser for Medical Products Regulation for 3 years in the WHO Regional Office for South-East Asia. In this position, he has been providing support to member states in strengthening their regulatory systems and has also acted as secretariat for SEARN, the South-East Asia Regulatory Network. Before joining WHO, he worked on regulatory processes, compassionate use, clinical trials, and marketing authorizations for the UK and French medicines agencies. His last position was representing France in the EMA’s pharmacovigilance committee, the PRAC.